These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12641451)

  • 1. Specificity determinants of human cathepsin s revealed by crystal structures of complexes.
    Pauly TA; Sulea T; Ammirati M; Sivaraman J; Danley DE; Griffor MC; Kamath AV; Wang IK; Laird ER; Seddon AP; Ménard R; Cygler M; Rath VL
    Biochemistry; 2003 Mar; 42(11):3203-13. PubMed ID: 12641451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of human cathepsin S.
    McGrath ME; Palmer JT; Brömme D; Somoza JR
    Protein Sci; 1998 Jun; 7(6):1294-302. PubMed ID: 9655332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide ketobenzoxazole inhibitors bound to cathepsin K.
    McGrath ME; Sprengeler PA; Hill CM; Martichonok V; Cheung H; Somoza JR; Palmer JT; Janc JW
    Biochemistry; 2003 Dec; 42(51):15018-28. PubMed ID: 14690410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of selective, nonpeptidic nitrile inhibitors of cathepsin s using the substrate activity screening method.
    Patterson AW; Wood WJ; Hornsby M; Lesley S; Spraggon G; Ellman JA
    J Med Chem; 2006 Oct; 49(21):6298-307. PubMed ID: 17034136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
    Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
    J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of human procathepsin X: a cysteine protease with the proregion covalently linked to the active site cysteine.
    Sivaraman J; Nägler DK; Zhang R; Ménard R; Cygler M
    J Mol Biol; 2000 Jan; 295(4):939-51. PubMed ID: 10656802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for reversible and irreversible inhibition of human cathepsin L by their respective dipeptidyl glyoxal and diazomethylketone inhibitors.
    Shenoy RT; Sivaraman J
    J Struct Biol; 2011 Jan; 173(1):14-9. PubMed ID: 20850545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxy-monopeptidase substrate specificity of human cathepsin X.
    Devanathan G; Turnbull JL; Ziomek E; Purisima EO; Ménard R; Sulea T
    Biochem Biophys Res Commun; 2005 Apr; 329(2):445-52. PubMed ID: 15737607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring inhibitor binding at the S' subsites of cathepsin L.
    Chowdhury SF; Joseph L; Kumar S; Tulsidas SR; Bhat S; Ziomek E; Ménard R; Sivaraman J; Purisima EO
    J Med Chem; 2008 Mar; 51(5):1361-8. PubMed ID: 18278855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chain.
    Rückrich T; Brandenburg J; Cansier A; Müller M; Stevanović S; Schilling K; Wiederanders B; Beck A; Melms A; Reich M; Driessen C; Kalbacher H
    Biol Chem; 2006; 387(10-11):1503-11. PubMed ID: 17081125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species differences between human and rat in the substrate specificity of cathepsin K.
    Tada S; Tsutsumi K; Ishihara H; Suzuki K; Gohda K; Teno N
    J Biochem; 2008 Oct; 144(4):499-506. PubMed ID: 18664521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the binding preferences/specificity in the active site of human cathepsin E.
    Rao-Naik C; Guruprasad K; Batley B; Rapundalo S; Hill J; Blundell T; Kay J; Dunn BM
    Proteins; 1995 Jun; 22(2):168-81. PubMed ID: 7567964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crystal and molecular structures of a cathepsin K:chondroitin sulfate complex.
    Li Z; Kienetz M; Cherney MM; James MN; Brömme D
    J Mol Biol; 2008 Oct; 383(1):78-91. PubMed ID: 18692071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a potent and selective noncovalent cathepsin S inhibitor.
    Thurmond RL; Sun S; Sehon CA; Baker SM; Cai H; Gu Y; Jiang W; Riley JP; Williams KN; Edwards JP; Karlsson L
    J Pharmacol Exp Ther; 2004 Jan; 308(1):268-76. PubMed ID: 14566006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 1.
    Liu H; Tully DC; Epple R; Bursulaya B; Li J; Harris JL; Williams JA; Russo R; Tumanut C; Roberts MJ; Alper PB; He Y; Karanewsky DS
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4979-84. PubMed ID: 16183279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.
    Tavares FX; Boncek V; Deaton DN; Hassell AM; Long ST; Miller AB; Payne AA; Miller LR; Shewchuk LM; Wells-Knecht K; Willard DH; Wright LL; Zhou HQ
    J Med Chem; 2004 Jan; 47(3):588-99. PubMed ID: 14736240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition mechanism of cathepsin L-specific inhibitors based on the crystal structure of papain-CLIK148 complex.
    Tsuge H; Nishimura T; Tada Y; Asao T; Turk D; Turk V; Katunuma N
    Biochem Biophys Res Commun; 1999 Dec; 266(2):411-6. PubMed ID: 10600517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the substrate specificity of mouse cathepsin P.
    Puzer L; Barros NM; Oliveira V; Juliano MA; Lu G; Hassanein M; Juliano L; Mason RW; Carmona AK
    Arch Biochem Biophys; 2005 Mar; 435(1):190-6. PubMed ID: 15680921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors: part 1.
    Lee-Dutra A; Wiener DK; Arienti KL; Liu J; Mani N; Ameriks MK; Axe FU; Gebauer D; Desai PJ; Nguyen S; Randal M; Thurmond RL; Sun S; Karlsson L; Edwards JP; Jones TK; Grice CA
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2370-4. PubMed ID: 20153648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined crystallographic and molecular dynamics study of cathepsin L retrobinding inhibitors.
    Shenoy RT; Chowdhury SF; Kumar S; Joseph L; Purisima EO; Sivaraman J
    J Med Chem; 2009 Oct; 52(20):6335-46. PubMed ID: 19761244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.